Abstract
Purpose. 5-MU, an α1A-adrenergic antagonist and 5-hydroxytryptamine (serotonin) agonist, reduces intraocular pressure (IOP) and pupil size in normal and glaucomatous eyes of monkeys. An investigation was carried out to determine the mechanism by which 5-MU reduces IOP when applied topically. Methods. Before and after unilateral application of 50μl of 2% 5-MU, tonographic outflow facility (C) and fluorophotometric aqueous humor flow (F) were measured in 8 normal cynomolgus monkeys. Uveoscleral outflow facility (Fu) was measured by a perfusion technique with FITC-dextran in 8 rabbits. Results. Compared with baseline values, C was increased by 51% (P < 0.01) in the treated eyes, and 16% (P > 0.10) in the contralateral control eyes at 1 hr after a single dose of 2% 5-MU. F was increased by 11% (P < 0.01) over a period of 4 hrs in the treated eyes, and by 3% (P > 0.10) in the contralateral control eyes after drug administration. Fu was unchanged (P > 0.30) at 1 hr following a single dose application. Conclusion. 5-MU reduces IOP by increasing outflow facility.
Original language | English |
---|---|
Pages (from-to) | S836 |
Journal | Investigative Ophthalmology and Visual Science |
Volume | 37 |
Issue number | 3 |
State | Published - 15 Feb 1996 |